| | |
| | |
| Clinical data | |
|---|---|
| Trade names | Anbesol, Lanacane, Orajel, others |
| AHFS/Drugs.com | |
| Routes of administration | Topical, Oral |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.002.094 |
| Chemical and physical data | |
| Formula | C9H11NO2 |
| Molar mass | 165.192 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Benzocaine, sold under the brand name Orajel amongst others, is a local anesthetic, belonging to the amino ester drug class, commonly used as a topical painkiller or in cough drops. It is the active ingredient in many over-the-counter anesthetic ointments such as products for oral ulcers. It is combined with antipyrine to form A/B ear drops. In the US, products containing benzocaine for oral application are contraindicated in children younger than two years old. [2] [3]
It was first synthesised in 1890 in Germany and approved for medical use in 1902. [4]
Benzocaine is indicated to treat a variety of pain-related conditions. It may be used for:
Examples of combination medications of benzocaine include:
Benzocaine is used as a key ingredient in numerous pharmaceuticals:
Benzocaine can come in a variety of preparations including:
Oral preparations:
Topical preparations:
Otic preparations:
Benzocaine is generally well tolerated and non-toxic when applied topically as recommended. [21]
However, there have been reports of serious, life-threatening adverse effects (e.g., seizures, coma, irregular heart beat, respiratory depression) with over-application of topical products or when applying topical products that contain high concentrations of benzocaine to the skin. [22]
The topical use of higher concentration (10–20%) benzocaine products applied to the mouth or mucous membranes has been found to be a cause of methemoglobinemia, a disorder in which the amount of oxygen carried by the blood is greatly reduced. [23]
Benzocaine may cause allergic reactions. [24] [25] [26] [27] These include:
Benzocaine is the ethyl ester of p-aminobenzoic acid (PABA). It can be prepared from PABA and ethanol [29] by Fischer esterification or via the reduction of ethyl p-nitrobenzoate. Benzocaine is sparingly soluble in water; it is more soluble in dilute acids and very soluble in ethanol, chloroform, and ethyl ether. The melting point of benzocaine is 88–92 °C, [30] and the boiling point is about 310 °C. [31] The density of benzocaine is 1.17 g/cm3.
Benzocaine can be prepared by esterification using 4-aminobenzoic acid and ethanol. [32] [33] It can also be prepared by reduction of ethyl 4-nitrobenzoate to the amine. [34] [35] In industrial practice, the reducing agent is usually iron and water in the presence of a little acid. [36]
Benzocaine was first synthesized in 1890 by the German chemist Eduard Ritsert (1859–1946), [37] in the town of Eberbach [38] and introduced to the market in 1902 under the name "Anästhesin". [39] [40]
Benzocaine is found, particularly in Britain, as an additive in street cocaine and also as a bulking agent in "legal highs". [41] Benzocaine gives a numbing effect similar to cocaine and as a bulking and binding agent it can not be detected once mixed. It is the most popular cutting agent worldwide. [42]
Bath solutions of benzocaine and its derivatives are commonly used to anesthetize amphibians for surgery. [43] [44] Benzocaine-based anesthetics are potent and highly effective for both anesthesia and euthanasia in amphibians. [45]